Efficacy of add-on sublingual immunotherapy for adults with asthma
- 24 May 2018
- journal article
- review article
- Published by Elsevier BV in Annals of Allergy, Asthma & Immunology
- Vol. 121 (2), 186-194
- https://doi.org/10.1016/j.anai.2018.05.019
Abstract
No abstract availableFunding Information
- National Nature Science Foundation of China (81270078, 81470211)
- Shanghai 3 Year Plan of the Key Subjects Construction in Public Health-Infectious Disease and Pathogenic Microorganism (15GWZK0102)
This publication has 33 references indexed in Scilit:
- In vitro and ex vivo models of human asthmaEuropean Journal of Pharmaceutics and Biopharmaceutics, 2013
- Update on optimal use of omalizumab in management of asthmaJournal of Asthma and Allergy, 2011
- Olea sublingual allergoid immunotherapy administered with two different treatment regimensAllergy and Asthma Proceedings, 2010
- Effectiveness of high dose sublingual immunotherapy to induce a stepdown of seasonal asthma: a pilot studyCurrent Medical Research and Opinion, 2009
- The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA²LEN meta‐analysisAllergy, 2009
- Global strategy for asthma management and prevention: GINA executive summaryEuropean Respiratory Journal, 2008
- Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trialsAnnals of Allergy, Asthma & Immunology, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996